Literature DB >> 12189140

Radicicol-sensitive peptide binding to the N-terminal portion of GRP94.

Shawn Vogen1, Tali Gidalevitz, Chhanda Biswas, Birgitte B Simen, Eytan Stein, Funda Gulmen, Yair Argon.   

Abstract

GRP94 is a molecular chaperone that carries immunologically relevant peptides from cell to cell, transferring them to major histocompatibility proteins for presentation to T cells. Here we examine the binding of several peptides to recombinant GRP94 and study the regulation and site of peptide binding. We show that GRP94 contains a peptide-binding site in its N-terminal 355 amino acids. A number of peptides bind to this site with low on- and off-rates and with specificity that is distinct from that of another endoplasmic reticulum chaperone, BiP/GRP78. Binding to the N-terminal fragment is sufficient to account for the peptide binding activity of the entire molecule. Peptide binding is inhibited by radicicol, a known inhibitor of the chaperone activities of HSP90-family proteins. However, the peptide-binding site is distinct from the radicicol-binding pocket, because both can bind to the N-terminal fragment simultaneously. Furthermore, peptide binding does not cause the same conformational change as does binding of radicicol. When the latter binds to the N-terminal domain, it induces a conformational change in the downstream, acidic domain of GRP94, as measured by altered gel mobility and loss of an antibody epitope. These results relate the peptide-binding activity of GRP94 to its other function as a chaperone.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12189140     DOI: 10.1074/jbc.M205323200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  29 in total

Review 1.  GRP94: An HSP90-like protein specialized for protein folding and quality control in the endoplasmic reticulum.

Authors:  Michal Marzec; Davide Eletto; Yair Argon
Journal:  Biochim Biophys Acta       Date:  2011-11-03

2.  Cellular protein is the source of cross-priming antigen in vivo.

Authors:  Lianjun Shen; Kenneth L Rock
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-20       Impact factor: 11.205

3.  Development of a Grp94 inhibitor.

Authors:  Adam S Duerfeldt; Laura B Peterson; Jason C Maynard; Chun Leung Ng; Davide Eletto; Olga Ostrovsky; Heather E Shinogle; David S Moore; Yair Argon; Christopher V Nicchitta; Brian S J Blagg
Journal:  J Am Chem Soc       Date:  2012-05-29       Impact factor: 15.419

4.  Enhancement of humoral immune responses to HBsAg by heat shock protein gp96 and its N-terminal fragment in mice.

Authors:  Hong-Tao Li; Jia-Bin Yan; Jing Li; Ming-Hai Zhou; Xiao-Dong Zhu; Yu-Xia Zhang; Po Tien
Journal:  World J Gastroenterol       Date:  2005-05-21       Impact factor: 5.742

5.  Re-examination of CD91 function in GRP94 (glycoprotein 96) surface binding, uptake, and peptide cross-presentation.

Authors:  Angela R Jockheck-Clark; Edith V Bowers; Mariam B Totonchy; Julie Neubauer; Salvatore V Pizzo; Christopher V Nicchitta
Journal:  J Immunol       Date:  2010-11-03       Impact factor: 5.422

6.  Heat shock protein gp96 is a master chaperone for toll-like receptors and is important in the innate function of macrophages.

Authors:  Yi Yang; Bei Liu; Jie Dai; Pramod K Srivastava; David J Zammit; Leo Lefrançois; Zihai Li
Journal:  Immunity       Date:  2007-02-01       Impact factor: 31.745

Review 7.  Adapting to stress - chaperome networks in cancer.

Authors:  Suhasini Joshi; Tai Wang; Thaís L S Araujo; Sahil Sharma; Jeffrey L Brodsky; Gabriela Chiosis
Journal:  Nat Rev Cancer       Date:  2018-09       Impact factor: 60.716

Review 8.  Protein folding in the endoplasmic reticulum.

Authors:  Ineke Braakman; Daniel N Hebert
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-05-01       Impact factor: 10.005

9.  Escherichia coli interaction with human brain microvascular endothelial cells induces signal transducer and activator of transcription 3 association with the C-terminal domain of Ec-gp96, the outer membrane protein A receptor for invasion.

Authors:  Ravi Maruvada; Yair Argon; Nemani V Prasadarao
Journal:  Cell Microbiol       Date:  2008-08-15       Impact factor: 3.715

10.  Experimental Anti-Inflammatory Drug Semapimod Inhibits TLR Signaling by Targeting the TLR Chaperone gp96.

Authors:  Jin Wang; Anatoly V Grishin; Henri R Ford
Journal:  J Immunol       Date:  2016-05-18       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.